OncoHost transforms precision medicine with PROphet®, a plasma-based, proteomic analysis tool. Its initial offering PROphetNSCLC® uses a blood sample to guide 1L immunotherapy decision-making. The test provides clear clinical utility by offering physicians crucial guidance on the optimal treatment plan for each patient, with a significant effect on overall survival.